Literature DB >> 2247313

Study of verbal description in neuropathic pain.

F Boureau1, J F Doubrère, M Luu.   

Abstract

The aim of this paper is to study the quality of verbal description and its diagnostic value in neuropathic pain. The verbal description of pain as assessed by a French adjective list questionnaire (QDSA) is compared between a group of 100 patients with neuropathic pain and a mixed group of 97 chronic benign and cancer non-neuropathic pain patients. Seventeen descriptors of the 61 QDSA descriptors have a significant intergroup frequency difference. By principal component analysis and Varimax rotation of the intercorrelation matrix of descriptors in the neuropathic group. 7 factors accounting for 66.0% of the total variance are derived. Six factors reflect purely sensory or affective aspects of the pain experience. Seven descriptors from the discriminant analysis function correctly assign 77% of neuropathic pain patients and 81% of the non-neuropathic pain patients. In a second neuropathic pain group of 32 patients, the discriminant function coefficient permits correct diagnostic categorization in 66% of the cases. Implications for clinical practice and trials are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2247313     DOI: 10.1016/0304-3959(90)91158-F

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  30 in total

1.  Differences in pain location, intensity, and quality by pain pattern in outpatients with cancer.

Authors:  Srisuda Ngamkham; Janean E Holden; Diana J Wilkie
Journal:  Cancer Nurs       Date:  2011 May-Jun       Impact factor: 2.592

2.  Difficult problems and their solutions in patients with cancer pain of the head and neck areas.

Authors:  T Sist; C Wong
Journal:  Curr Rev Pain       Date:  2000

3.  Breast Cancer EDGE Task Force Outcomes: Clinical Measures of Pain.

Authors:  Shana Harrington; Laura Gilchrist; Antoinette Sander
Journal:  Rehabil Oncol       Date:  2014

Review 4.  [Distinctive features of orofacial pain perception].

Authors:  B Steiger; D Ettlin
Journal:  Schmerz       Date:  2015-04       Impact factor: 1.107

5.  Pain Quality by Location in Outpatients with Cancer.

Authors:  Judith M Schlaeger; Li-Chueh Weng; Hsiu-Li Huang; Hsiu-Hsin Tsai; Miho Takayama; Srisuda Ngamkham; Yingwei Yao; Diana J Wilkie
Journal:  Pain Manag Nurs       Date:  2019-05-31       Impact factor: 1.929

6.  New consensus multivariate models based on PLS and ANN studies of sigma-1 receptor antagonists.

Authors:  Aline A Oliveira; Célio F Lipinski; Estevão B Pereira; Kathia M Honorio; Patrícia R Oliveira; Karen C Weber; Roseli A F Romero; Alexsandro G de Sousa; Albérico B F da Silva
Journal:  J Mol Model       Date:  2017-10-02       Impact factor: 1.810

7.  Relationship of Pain Quality Descriptors and Quantitative Sensory Testing: Sickle Cell Disease.

Authors:  Brenda W Dyal; Miriam O Ezenwa; Saunjoo L Yoon; Roger B Fillingim; Yingwei Yao; Judith M Schlaeger; Marie L Suarez; Zaijie J Wang; Robert E Molokie; Diana J Wilkie
Journal:  Nurs Res       Date:  2019 Sep/Oct       Impact factor: 2.381

8.  Cetuximab alleviates neuropathic pain despite tumour progression.

Authors:  Christian Kersten; Marte Grønlie Cameron
Journal:  BMJ Case Rep       Date:  2012-06-14

9.  Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors.

Authors:  D J Wilkie; H Y Huang; N Reilly; K C Cain
Journal:  J Pain Symptom Manage       Date:  2001-11       Impact factor: 3.612

10.  A registry of the aetiology and costs of neuropathic pain in pain clinics : results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study.

Authors:  Manuel J Rodríguez; Antonio J García
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.